EXPERIENCE WITH VEMURAFENIB IN THE TREATMENT OF HAIRY CELL LEUKEMIA

被引：0
|
作者：
Sari, E. [1 ]
Baghy, K. [2 ]
Kovalszky, I. [2 ]
Boedoer, C. [2 ]
Rajnai, H. [2 ]
Csomor, J. [2 ]
Nagy, Z. [1 ]
Demeter, J. [1 ]
机构：
[1] Semmelweis Univ, Dept Internal Med 1, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1782
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [1] Vemurafenib As First Treatment of Hairy Cell Leukemia
    Cheng, Gregory
    Cheng, Gym
    Chan, Natalie Pui Ha
    Wong, Chris
    Wong, Raymond S.
    BLOOD, 2014, 124 (21)
  • [2] Combination of rituximab and vemurafenib in the treatment of Hairy Cell Leukemia
    Stocker, Nicolas
    HEMATOLOGIE, 2021, 27 (05): : 219 - 219
  • [3] VEMURAFENIB IN REFRACTORY HAIRY CELL LEUKEMIA: EXPERIENCE OF USE IN A CENTRE
    Ignacio, Casas-Aviles
    Raul, Siguenza
    Leal Francisco, Perez
    Sara, Caceres
    Fernando, Carnicero
    Jose, Arcos M.
    Helena, Banas M.
    Fatima, Ibanez
    Carmen, Cabrera
    Juan, Bergua
    HAEMATOLOGICA, 2016, 101 : 209 - 210
  • [4] Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
    Kaya, Suereyya Yigit
    Mutlu, Yasa Gul
    Malkan, Umit Yavuz
    Mehtap, Ozgur
    Karadag, Fatma Keklik
    Korkmaz, Gulten
    Elverdi, Tugrul
    Saydam, Gueray
    Ozet, Guelsuem
    Ar, Muhlis Cem
    Melek, Elif
    Maral, Senem
    Kaynar, Leylagul
    Sevindik, Omuer Gokmen
    LEUKEMIA RESEARCH, 2024, 140
  • [5] Efficacy of Vemurafenib in Hairy-Cell Leukemia
    Samuel, Jesvin
    Macip, Salvador
    Dyer, Martin J. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (03): : 286 - 288
  • [6] BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib
    Sascha, Dietrich
    Pircher, Andreas
    Andrulis, Mindaugas
    Ellert, Elena
    Peyrade, Frederic
    Wendtner, Clemens-Martin
    Follows, George A.
    Dyer, Martin J. S.
    Elter, Thomas
    Zeiser, Robert
    Gaehler, Anita
    Herrmann, Michael
    Herold, Michael
    Dearden, Claire
    Glimm, Hanno
    Hallek, Michael
    Ho, Anthony D.
    Steurer, Michael
    Zenz, Thorsten
    BLOOD, 2014, 124 (21)
  • [7] Rituximab-Vemurafenib Combination for the Treatment of Relapsed/Refractory Hairy Cell Leukemia
    Sevindik, Omur
    Gemici, Aliihsan
    Mutlu, Yasa Gul
    Aydin, Berrin Balik
    Cakir, Asli
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S286 - S286
  • [8] Interest of vemurafenib in relapsed or refractory hairy cell leukemia
    Philippe, Laure
    HEMATOLOGIE, 2015, 21 (06): : 321 - 322
  • [9] Targeting MEK in vemurafenib-resistant hairy cell leukemia
    Rebecca Caeser
    Grace Collord
    Wen-Qing Yao
    Zi Chen
    George S. Vassiliou
    Philip A. Beer
    Ming-Qing Du
    Mike A. Scott
    George A. Follows
    Daniel J. Hodson
    Leukemia, 2019, 33 : 541 - 545
  • [10] Targeting MEK in vemurafenib-resistant hairy cell leukemia
    Caeser, Rebecca
    Collord, Grace
    Yao, Wen-Qing
    Chen, Zi
    Vassiliou, George S.
    Beer, Philip A.
    Du, Ming-Qing
    Scott, Mike A.
    Follows, George A.
    Hodson, Daniel J.
    LEUKEMIA, 2019, 33 (02) : 541 - 545
12345